FEMY - Femasys Operating income before deduction of amortization

Public company logo of Femasys (FEMY)

The unwavering trust of gynecologists in Femasys Inc. (FEMY) innovations strengthens the brand's position. Analyzing the EBITDA history on GURU.Markets, we see that the 0.00 value reflects the most recent operating profit. Revenues are based on the sale of office-based diagnostic tools reimbursed by insurers. Transparent investment audits and the top management's expertise in women's health guarantee the high-quality commercialization of products.

Femasys Inc. (FEMY) - Profit before payment of interest, taxes and amortization from 11/23/2025 to 11/11/2026

Summary analytical data breakdowns for Femasys (FEMY)

- stock quotes and analyst forecast:
Price Performance Chart Femasys Corporation|FEMY - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Femasys|FEMY - Total Company Value
- balance sheet equity data:
Equity per Share Femasys|FEMY - Company Book Value|Market Capitalization to Book Value femasys.com|FEMY - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital Femasys Inc.|FEMY - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Femasys Inc|FEMY - Company Total Debt|Debts to Book Capitalization Femasys|FEMY - Company Long-Term Debt|Company Current Liabilities Femasys|Immediate Liquidity femasys.com
- earnings and valuation multiples indicators:
FEMY - Company Net Income|Net Profit Forecast Femasys Inc.|FEMY - Price to Earnings Ratio|Market Cap to Future Earnings Ratio femasys.com|FEMY - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Femasys|FEMY - Operating profit EBITDA|Earnings per one share for the last 12 months Femasys|FEMY - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months femasys.com|FEMY - Earnings per share growth in current year|Expected earnings per share growth for next year Femasys Inc.
Fundamental company valuation:FEMY (Femasys Corporation)
Product sample of Femasys Inc

For Femasys Inc., whose dominance in women's health diagnostics is secured by patent protection and stringent FDA filters, operating profit serves as the primary indicator of how effectively these barriers are monetized. Analyzing the company's operating profit on the GURU.Markets platform via the calculated value 0.00 allows for an assessment of the real cash flow from core operations, stripped of accounting adjustments, which determines the fundamental value of the business.

Competitors of Femasys Inc. (FEMY)

Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|AngioDynamics Inc. - Operating profit before amortization|Cerus Corporation - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TKNO (teknova.com)|MGRM - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Sharps Technology, Inc. STSS|INFU: Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization UTMD (Utah Med)|KRMD (KORU Medical Systems, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization nyxoah.com NYXH|Profit before payment of interest, taxes and amortization Microbot Medical (MBOT)|Operating profit before deduction of amortization Pro-Dex Inc PDEX|Operating profit EBITDA ZTEK (Zentek Limited)|Operating profit EBITDA Elutia Corporation ELUT|MLSS - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization nexgel.com NXGL|RVP (retractable.com) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization harvardbioscience.com (HBIO)|Profit before payment of interest, taxes and amortization Meihua Medical Technologies|Predictive Oncology Corp (POAI) - Operating income before deduction of amortization|Operating profit before deduction of amortization CJMB (Callan JMB Inc)|ATRI (atrioncorp.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NURO (NeuroMetrix)